# Systemic Biomarkers to Predict Radiation-Induced Neurocognitive Decline

> **NCT06779487** · — · RECRUITING · sponsor: **Tata Memorial Centre** · enrollment: 200 (estimated)

## Conditions studied

- Brain Tumors
- Medulloblastoma
- Glioma
- Ependymoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06779487
- **Lead sponsor:** Tata Memorial Centre
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-11
- **Primary completion:** 2032-02
- **Final completion:** 2032-02
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06779487

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06779487, "Systemic Biomarkers to Predict Radiation-Induced Neurocognitive Decline". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06779487. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
